You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17331 - 17340 of 18145 results
  1. 4: Nanotechnology, Advanced Materials and Manufacturing (NM)

    Release Date: 09-07-2011Open Date: 11-02-2011Due Date: 12-02-2011Close Date: 12-02-2011

    The Nanotechnology, Advanced Materials and Manufacturing (NM) topic addresses innovations and development of new materials, devices, machines, structures and manufacturing processes for the advancement of the competitive nature and state of the art for U.S. industry. NM includes materials and manufacturing technologies such as electronic materials and processes, high temperature materials, structu ...

    SBIRPhase INational Science Foundation
  2. 1: NANOTECHNOLOGY

    Release Date: 09-07-2011Open Date: 11-02-2011Due Date: 12-02-2011Close Date: 12-02-2011

    The Nanotechnology subtopic addresses the creation and use of functional materials, devices, and systems with novel properties and functions that are achieved through the control of matter at a submicroscopic scale (from a fraction of nanometer to about 100 nm). Proposals should be market-driven and identify the end users of the proposed technology, and the proposed pathway to commercialization. ...

    SBIRPhase INational Science Foundation
  3. 2: ADVANCED MATERIALS

    Release Date: 09-07-2011Open Date: 11-02-2011Due Date: 12-02-2011Close Date: 12-02-2011

    The Advanced Materials subtopic addresses the development of new materials that can advance the competitive nature and state of the art for the U.S. industry. New materials and systems that have the potential for revolutionary changes and paradigm shifts will be given special consideration. Proposals should be market-driven and identify the end users of the proposed technology, and the proposed pa ...

    SBIRPhase INational Science Foundation
  4. 3: MANUFACTURING

    Release Date: 09-07-2011Open Date: 11-02-2011Due Date: 12-02-2011Close Date: 12-02-2011

    The manufacturing subtopic addresses manufacturing innovations that improve the efficiency and competitiveness of the nation's manufacturing sector. Proposals should be market-driven and identify the end users of the proposed technology, and the proposed pathway to commercialization. M1. Manufacturing Processes (Cognizant Program Officer: Grace Wangjiwang@nsf.gov) Innovative processes fo ...

    SBIRPhase INational Science Foundation
  5. RFA-DK-11-: Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas

    Release Date: 09-20-2011Open Date: 10-23-2011Due Date: 11-24-2011Close Date: 11-24-2011

    Type 1 diabetes (T1D) results from the autoimmune destruction of the insulin-producing cells of the pancreatic islets of Langerhans and affects more than one million Americans, usually with onset in childhood or young adulthood. The disease markedly impairs quality of life and shortens lifespan primarily through premature mortality. T1D is associated with numerous complications including blindnes ...

    SBIRPhase IDepartment of Health and Human Services
  6. 1: Enhancing Access to the Radio Spectrum (EARS)

    Release Date: 09-07-2011Open Date: 10-17-2011Due Date: 11-17-2011Close Date: 11-17-2011

    The fundamental mission of NSF is to promote discoveries and to advance education across the frontiers of knowledge in science and engineering. Consistent with that mission, NSF encourages and supports a wide range of proposals from the research and education community and from the private small business sector. These proposals are reviewed under NSF's merit review criteria, which cover both t ...

    STTRPhase INational Science Foundation
  7. 1: NATIONAL CANCER INSTITUTE (NCI)

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The NCI is the Federal Government’s principal agency established to conduct and support cancer research, training, health information dissemination, and other related programs. As the effector of the National Cancer Program, the NCI supports a comprehensive approach to the problems of cancer through intensive investigation in the cause, diagnosis, prevention, early detection, treatment, ...

    SBIRPhase IDepartment of Health and Human Services
  8. 255 : Development of Anticancer Agents

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The short term goal of this SBIR contract topic is to support small businesses that are developing novel candidate therapeutic agents of interest. The scope of work may include structure activity relationships (SAR), medicinal chemistry and formulation, animal efficacy testing, pharmacokinetic, pharmacodynamic, and toxicological studies, as well as production of GMP bulk drug and clinical ...

    SBIRPhase IDepartment of Health and Human Services
  9. 277: Development of Companion Diagnostic

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    Recently, the demand for companion diagnostics has greatly increased with the recognition that matching the right patient to the right drug can improve patient care and may decrease health care costs. More than a dozen companion diagnostic tests have been approved by the FDA to guide the prescription of products in oncology, cardiovascular disease, and infectious disease. Among them, tests of Phil ...

    SBIRPhase IDepartment of Health and Human Services
  10. 291: Development of Radiation Modulators For Use During Radiotherapy

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    Radiotherapy is employed in the treatment of over half of all cancer patients. Many of those patients however, may suffer some adverse effects from this therapy during and/or after treatment. In addition, in approximately half of the patients treated with curative intent, the tumors recur. Enhancing specific tumor killing and minimizing normal tissue damage from radiotherapy would improve tumor co ...

    SBIRPhase IDepartment of Health and Human Services
US Flag An Official Website of the United States Government